Nov. 10, 2025 ~ Alzheimer’s detection is becoming more proactive than ever. Lloyd Jackson highlights how Dr. Rany Aburashed, founder of Neurogen Biomarking, is helping lead the shift toward early diagnosis and personalized intervention. Using a simple blood test to detect biomarkers, Dr. Aburashed emphasizes that catching the disease before symptoms appear can dramatically change outcomes—giving patients and families a clearer path forward. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com

for information about our collection and use of personal data for

advertising.